Venous thromboembolism (VTE) remains a major global health concern, encompassing conditions such as deep venous thrombosis and pulmonary embolism. Rising disease prevalence, increasing awareness of thrombotic disorders, and advancements in anticoagulant therapies are contributing to sustained industry expansion across developed and emerging economies. The Venous Thromboembolism Drug Market...